RADNOR, PA — Avantor, Inc. (NYSE: AVTR) recently appointed Ludovic Brellier as Executive Vice President of its Bioscience & Medtech Products segment and Chief Transformation Officer, effective May 1, 2026.
Brellier will oversee growth of the company’s BMP business and lead operational improvement efforts, including enterprise-wide transformation initiatives through the Revival Management Office.
He joins Avantor from Danaher, where he most recently served as president of Cytiva’s Hardware Solutions business, overseeing five business units focused on biopharma innovation, manufacturing, and commercialization.
During his tenure at Cytiva, Brellier also held roles as president of Integrated Solutions & Services and vice president of business operations, and led efforts to establish Cytiva as a standalone operating company within Danaher, as well as the integration of Pall Life Sciences and Cytiva.
“Ludovic is a skilled operator who has a successful track record of growing bioprocessing businesses both organically and inorganically,” said Emmanuel Ligner, Avantor’s president and CEO.
Benoit Gourdier, the current executive vice president of the BMP segment, will remain with the company through the end of 2026, or earlier, to support the leadership transition.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.